HHC
AVNS

Hutchin Hill Capital’s Avanos Medical AVNS Stock Holding History

Hutchin Hill Capital’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-69,600
Closed -$2.73M – 736
2017
Q2 		$2.73M Buy
69,600
+17,900
+35% +$676K 0.09% 252
2017
Q1 		$1.97M Buy
51,700
+2,400
+5% +$93.5K 0.05% 332
2016
Q4 		$1.82M Buy
49,300
+6,400
+15% +$229K 0.06% 328
2016
Q3 		$1.49M Buy
42,900
+8,900
+26% +$312K 0.03% 305
2016
Q2 		$1.11M Buy
+34,000
New +$1.04M 0.04% 319
2015
Q2 		– Sell
-7,794
Closed -$383K – 648
2015
Q1 		$383K Buy
+7,794
New +$361K 0.01% 572

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Hutchin Hill Capital's AVNS Position: Q3 2017 in Review

Hutchin Hill Capital sold out of Avanos Medical (AVNS) in Q3 2017, closing a stake of 69,600 shares — an estimated $2.73M sold.

Hutchin Hill Capital first reported a position in AVNS in Q1 2015 and held it in 6 quarters. The position peaked at $2.73M in Q2 2017. 318 funds tracked by Wall St. Rank hold AVNS as of Q3 2017.

  • Hutchin Hill Capital reported no remaining Avanos Medical position as of Q3 2017 after selling out during the quarter.
  • Hutchin Hill Capital sold 69,600 Avanos Medical shares in Q3 2017, an estimated $2.73M.
  • Hutchin Hill Capital first reported a position in Avanos Medical in Q1 2015 and held it in 6 quarters.
  • Hutchin Hill Capital's Avanos Medical position peaked at $2.73M in Q2 2017.
  • 318 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2017.

Based on Hutchin Hill Capital's 13F filing for Q3 2017, filed 14 Nov 2017.